France's Novacap scoops up U.S. CDMO

PCI Synthesis, a CDMO based in the Boston area, is being acquired by France's Novacap. (PCI Synthesis)

Novacap, a French company that specializes in pharmaceutical synthesis and advanced specialties, is taking on new skills with the acquisition of a Massachusetts-based CDMO.

Novacap has a deal to buy Boston area-based PCI Synthesis, whose services include commercial production of new chemical entities, generic APIs as well as research and early stage development.

PCI has a manufacturing facility in Newburyport, Massachusetts, and an R&D facility in Devens, Massachusetts. Terms of the deal were not disclosed, but according to the announcement, PCI had about $32 million in sales last year.

Free Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This webinar will discuss the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

"The acquisition of PCI Synthesis perfectly fits with our strategic roadmap as it will strengthen our offering to the pharmaceutical industry and provide Novacap with a strong and innovative platform to accelerate our development in the U.S.,” Novacap CEO Pierre Luzeau said in a statement.

Based in Lyon, France, Novacap has 28 industrial plants, including 12 cGMP manufacturing sites, two main R&D centers and its comprehensive range of services. It has about 3,000 employees and tallied sales of $1 billion last year.


Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.